Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

For trials without tribulations, we must improve patient experience

Clinical trials are broken and only patients can help us fix them - if we let them

- PMLiVE

Breaking from tradition – social media at medical congresses

How social media can improve HCPs' experience

The role of brain health in treating MS

Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health,...

Blue Latitude Health

- PMLiVE

Streamlining clinical trials – why better data use is key

Big data, blockchain technology and artificial intelligence have given industry the chance to streamline drug trials, say experts, who agree with recent FDA calls for more efficient clinical research models.Dr...

- PMLiVE

New results back Sangamo, UniQure haemophilia gene therapies

Encouraging results for firms in four-way race

- PMLiVE

Europe urged to adapt faster to gene therapy challenges

Resistance to high prices, even with novel payment models

- PMLiVE

Wilmington Healthcare makes new senior appointment

Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has appointed Jonathan Carney as Director of its Insight and Key Account Management (KAM) services.

Wilmington Healthcare

- PMLiVE

Paul Morrissey joins OPEN Health

Will liaise with client procurement and lead expansion

- PMLiVE

M&F Health, 90TEN and Sanofi among big winners at Communiqué Awards

Full results from health comms awards

- PMLiVE

AstraZenca to appeal NICE rejection of Tagrisso

Pfizer’s Vizimpro wins recommendation

- PMLiVE

Citryll snares €15m backing for its autoimmune disease NETs

New approach to tackling diseases such as lupus, RA

- PMLiVE

NICE backs CDF funding for Sanofi/Regeneron’s skin cancer drug Libtayo

Acknowledges unmet need

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links